Dolby Laboratories, Inc. (NYSE:DLB) Shares Acquired by Zurcher Kantonalbank Zurich Cantonalbank

Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Dolby Laboratories, Inc. (NYSE:DLBFree Report) by 11.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 12,652 shares of the electronics maker’s stock after buying an additional 1,253 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Dolby Laboratories were worth $1,090,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Blue Trust Inc. boosted its holdings in Dolby Laboratories by 75.7% in the fourth quarter. Blue Trust Inc. now owns 369 shares of the electronics maker’s stock valued at $29,000 after purchasing an additional 159 shares in the last quarter. VisionPoint Advisory Group LLC boosted its holdings in Dolby Laboratories by 86.9% in the third quarter. VisionPoint Advisory Group LLC now owns 370 shares of the electronics maker’s stock valued at $29,000 after purchasing an additional 172 shares in the last quarter. Fifth Third Bancorp boosted its holdings in Dolby Laboratories by 175.3% in the third quarter. Fifth Third Bancorp now owns 446 shares of the electronics maker’s stock valued at $35,000 after purchasing an additional 284 shares in the last quarter. Platinum Investment Management Ltd. acquired a new position in Dolby Laboratories in the third quarter valued at approximately $109,000. Finally, Column Capital Advisors LLC boosted its holdings in Dolby Laboratories by 20.1% in the third quarter. Column Capital Advisors LLC now owns 1,462 shares of the electronics maker’s stock valued at $116,000 after purchasing an additional 245 shares in the last quarter. 58.56% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Dolby Laboratories

In other Dolby Laboratories news, SVP John D. Couling sold 33,560 shares of the business’s stock in a transaction that occurred on Friday, February 9th. The stock was sold at an average price of $80.81, for a total value of $2,711,983.60. Following the completion of the sale, the senior vice president now owns 108,519 shares in the company, valued at $8,769,420.39. The sale was disclosed in a document filed with the SEC, which is available through this link. 39.54% of the stock is owned by company insiders.

Dolby Laboratories Trading Down 0.9 %

Shares of NYSE DLB opened at $79.20 on Friday. Dolby Laboratories, Inc. has a twelve month low of $75.87 and a twelve month high of $91.01. The stock has a 50 day moving average of $81.62 and a two-hundred day moving average of $83.31. The stock has a market cap of $7.57 billion, a P/E ratio of 41.04 and a beta of 0.97.

Dolby Laboratories (NYSE:DLBGet Free Report) last issued its quarterly earnings data on Thursday, February 1st. The electronics maker reported $0.76 earnings per share for the quarter, beating analysts’ consensus estimates of $0.62 by $0.14. Dolby Laboratories had a return on equity of 10.21% and a net margin of 14.70%. The company had revenue of $315.57 million during the quarter, compared to analysts’ expectations of $310.98 million. As a group, research analysts predict that Dolby Laboratories, Inc. will post 2.6 earnings per share for the current year.

Dolby Laboratories Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, February 22nd. Shareholders of record on Tuesday, February 13th were paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.52%. The ex-dividend date of this dividend was Monday, February 12th. Dolby Laboratories’s dividend payout ratio is currently 62.18%.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the company. Rosenblatt Securities reaffirmed a “buy” rating and issued a $98.00 price target on shares of Dolby Laboratories in a report on Wednesday, January 31st. StockNews.com raised Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Friday, February 2nd.

View Our Latest Report on Dolby Laboratories

Dolby Laboratories Company Profile

(Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Featured Stories

Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories, Inc. (NYSE:DLBFree Report).

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.